CIK 0001099800 · Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364316614
- Phone
- 9492502500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-07 | Chopra Daveen CVP, TMTT & Surgical | Shares withheld for taxes | −674 | $83.20 | $56K | 40,920 |
| 2026-05-07 | Chopra Daveen CVP, TMTT & Surgical | Grant or award · Employee Stock Option (Right to Acquire) | +49,100 | 49,100 | ||
| 2026-05-07 | Chopra Daveen CVP, TMTT & Surgical | Grant or award · Performance Rights | +9,675 | 9,675 | ||
| 2026-05-07 | Bruls Annette CVP, EMEACLA | Grant or award | +6,650 | 20,821 | ||
| 2026-05-07 | Bruls Annette CVP, EMEACLA | Grant or award · Employee Stock Option (Right to Acquire) | +33,700 | 33,700 | ||
| 2026-05-07 | Bruls Annette CVP, EMEACLA | Grant or award · Performance Rights | +6,650 | 6,650 | ||
| 2026-05-05 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise | +13,000 | $59.26 | $770K | 52,079 |
| 2026-05-05 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −11,131 | $82.91 | $923K | 40,948 |
| 2026-05-05 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) | −13,000 | 0 | ||
| 2026-05-05 | Zovighian Bernard J CEO | Gift | −523 | 80,257.65 | ||
| 2026-05-05 | Zovighian Bernard J CEO | Gift | +523 | 12,039.55 | ||
| 2026-05-04 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +1,019 | $59.26 | $60K | 34,700.91 |
| 2026-05-04 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −1,019 | $83.98 | $86K | 33,681.91 |
| 2026-05-04 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −1,019 | 0 | ||
| 2026-05-03 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −620 | $83.98 | $52K | 39,079 |
| 2026-05-03 | Zovighian Bernard J CEO | Shares withheld for taxes | −515 | $83.98 | $43K | 80,780.65 |
| 2026-05-03 | Lippis Daniel J. CVP, TAVR | Shares withheld for taxes 10b5-1 | −252 | $83.98 | $21K | 33,681.91 |
| 2026-05-03 | Chopra Daveen CVP, TMTT & Surgical | Shares withheld for taxes | −282 | $83.98 | $24K | 31,919 |
| 2026-05-03 | BOBO DONALD E JR CVP,Strategy/Corp Development | Shares withheld for taxes | −469 | $83.98 | $39K | 20,797.25 |
| 2026-05-01 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +1,019 | $59.26 | $60K | 34,952.91 |
Page 7 of 13 · 249 trades